Conventional thawing strategies, including swirling vials in tepid to warm water baths or rolling vials between hands can lead to adjustable cell viabilities and will increase contamination worries. Dr. Rolf O. Ehrhardt, CEO of BioCision, stated: As even more cell therapies reach past due stage medical trials and commercialization, the necessity to standardize and de-risk cell managing, including thawing, is now critical. The ThawSTAR program has been proven to considerably improve cell viability and recovery compared to conventional methods, and may improve the regularity of therapeutic outcomes ultimately. BioCision can be developing other vial forms to address the requirements of the bigger cell therapy market..Does it work? It do for Col. Amy Bechtold. The Air flow Force judge survived tours in Bosnia and Afghanistan but almost died after a poor case of tinnitus led her to seek medical care, which revealed an aneurysm in her mind. Her neurosurgeon, Dr. Christopher Koebbe, said she required immediate surgery. The threat of an aneurysm is certainly that it could rupture, causing a massive human brain hemorrhage, he informed CBS News. If that were to happen, there would be a 50 to 60 % chance that a individual would die or be disabled from that hemorrhage. Death and disability from ruptured aneurysms affect 25, 000 people each year, according to the Brain Aneurysm Basis.